Detection of Anti-Infliximab Antibodies and Identifying Factors affecting their Occurrence Using Elisa Method among Patients with Immune-Mediated Inflammatory Diseases

Authors

  • Hala F. Kasim
  • Souzan H. Eassa
  • Hishyar M. Salih

DOI:

https://doi.org/10.37506/ijfmt.v15i3.15767

Keywords:

Infliximab – Antibodies – Biological drugs – Immunogenicity – ELISA.

Author Biographies

Hala F. Kasim

Instructor, Department of Clinical Pharmacy, College of Pharmacy, University of Duhok, Kurdistan Region, Iraq

Souzan H. Eassa

Lecturer, Department of Clinical Pharmacy, College of Pharmacy, University of Duhok, Kurdistan Region, Iraq

Hishyar M. Salih

Assistant Professor Department of
Anatomy and Biology, College of Medicine, University of Duhok, Kurdistan Region, Iraq

Published

2021-05-17

How to Cite

Hala F. Kasim, Souzan H. Eassa, & Hishyar M. Salih. (2021). Detection of Anti-Infliximab Antibodies and Identifying Factors affecting their Occurrence Using Elisa Method among Patients with Immune-Mediated Inflammatory Diseases. Indian Journal of Forensic Medicine & Toxicology, 15(3), 3047-3058. https://doi.org/10.37506/ijfmt.v15i3.15767